Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3C15M | ISIN: CA67577H1047 | Ticker-Symbol: 2QB0
Frankfurt
06.06.25 | 08:01
0,194 Euro
+1,57 % +0,003
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
OCUMETICS TECHNOLOGY CORP Chart 1 Jahr
5-Tage-Chart
OCUMETICS TECHNOLOGY CORP 5-Tage-Chart

Aktuelle News zur OCUMETICS TECHNOLOGY Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiOcumetics Technology Corp: Ocumetics Technology arranges $2.1-million financing-
MiOcumetics Technology Corp.: Ocumetics Announces Private Placement1
MiOcumetics Technology Corp: Ocumetics sets June 26 as start date for FIH study1
DiNorthern Dynasty, Ocumetics, Star Copper at 52-Week Highs on News22
DiOcumetics Technology Corp.: Ocumetics Targets June 26, 2025 for Commencement of its First in Human Study1
OCUMETICS TECHNOLOGY Aktie jetzt für 0€ handeln
DiOcumetics Technology Corp: Ocumetics to hold intraocular lens FIH clinical study1
MoOcumetics Technology Corp.: Ocumetics Announces Mexico City as Site for its First in Human Study1
23.05.Ocumetics Technology Corp: Ocumetics submits FIH clinical study protocol to IRB2
22.05.Ocumetics Technology Corp.: Ocumetics Clinical Study Protocol Submission and Site Initiation on Schedule for Summer 20251
15.05.Ocumetics Technology Corp: Ocumetics makes lens for human clinical study in summer1
14.05.Ocumetics Technology Corp.: Ocumetics Completes Manufacturing of Lenses to be used in First-in-Human Study3
13.05.Ocumetics Technology Corp: Ocumetics begins lens design freeze for FIH study3
12.05.Ocumetics Technology Corp.: Ocumetics Announces Lens Design Freeze for First-in-Human Study1
08.05.Ocumetics' corrective lens meets key milestone before human trials1
08.05.Ocumetics Technology Corp.: Ocumetics Achieves Key Milestone: Laboratory Testing Confirms Accommodative Power Target was Successfully Achieved in Preparation for First-in-Human Trials2
02.05.Ocumetics Technology Corp: Ocumetics director Marks resigns3
01.05.Ocumetics Technology Corp.: Ocumetics Announces Corporate Changes1
23.04.Ocumetics Technology Corp: Ocumetics completes milestones for FIH clinical study2
22.04.Ocumetics Technology Corp.: Ocumetics Announces Completion of Major Milestones First-In-Human Surgery Planned for Summer 20252
24.03.Ocumetics Technology Corp: Ocumetics hires Independent Trading for market-making1
Weiter >>
26 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1